The challenge of prostate cancer drug approval versus reimbursement
Here at the European Association of Urology (EAU) congress in Paris, there are some interesting debates amongst delegates attending the meeting regarding new therapies either recently – or about to be approved – for castrate-resistant prostate cancer (CRPC). For example: … Continue reading ? read more..
You have a real ability to write a content that is helpful for us. Thank you for your efforts in sharing such blogs to us. Texas Urology Physician Jobs
ReplyDelete